Association of high-level MRP1 expression with poor clinical outcome in a large prospective study of primary neuroblastoma.
about
Chemoresistance induces enhanced adhesion and transendothelial penetration of neuroblastoma cells by down-regulating NCAM surface expressionSmall-molecule multidrug resistance-associated protein 1 inhibitor reversan increases the therapeutic index of chemotherapy in mouse models of neuroblastoma.Paclitaxel sensitivity in relation to ABCB1 expression, efflux and single nucleotide polymorphisms in ovarian cancerTargeting the Achilles heel of multidrug-resistant cancer by exploiting the fitness cost of resistance.Direct and coordinate regulation of ATP-binding cassette transporter genes by Myc factors generates specific transcription signatures that significantly affect the chemoresistance phenotype of cancer cells.ABCA transporter gene expression and poor outcome in epithelial ovarian cancer.Update information on drug metabolism systems--2009, part II: summary of information on the effects of diseases and environmental factors on human cytochrome P450 (CYP) enzymes and transporters.The effect of vorinostat on the development of resistance to doxorubicin in neuroblastoma.Drug resistance in cancer: an overview.Multidrug resistance protein 1 (MRP1, ABCC1), a "multitasking" ATP-binding cassette (ABC) transporter.miR-380-5p represses p53 to control cellular survival and is associated with poor outcome in MYCN-amplified neuroblastoma.ODC1 is a critical determinant of MYCN oncogenesis and a therapeutic target in neuroblastoma.ABCC multidrug transporters in childhood neuroblastoma: clinical and biological effects independent of cytotoxic drug efflux.A single-arm pilot phase II study of gefitinib and irinotecan in children with newly diagnosed high-risk neuroblastoma.Chimeric MicroRNA-1291 Biosynthesized Efficiently in Escherichia coli Is Effective to Reduce Target Gene Expression in Human Carcinoma Cells and Improve Chemosensitivity.Nuclear receptors in the multidrug resistance through the regulation of drug-metabolizing enzymes and drug transporters.Regulation of drug resistance by human pregnane X receptor in breast cancer.Regulation of ABC efflux transporters at blood-brain barrier in health and neurological disorders.Detection of GD2-positive cells in bone marrow samples and survival of patients with localised neuroblastoma.Multidrug Resistance-associated Protein-1 (MRP-1)-dependent Glutathione Disulfide (GSSG) Efflux as a Critical Survival Factor for Oxidant-enriched Tumorigenic Endothelial CellsMembrane expression of MRP-1, but not MRP-1 splicing or Pgp expression, predicts survival in patients with ESFT.Functional diversification of sea urchin ABCC1 (MRP1) by alternative splicingMcl1 downregulation sensitizes neuroblastoma to cytotoxic chemotherapy and small molecule Bcl2-family antagonists.Small nucleolar RNA-derived microRNA hsa-miR-1291 modulates cellular drug disposition through direct targeting of ABC transporter ABCC1ABCB1 (MDR1) polymorphisms and ovarian cancer progression and survival: a comprehensive analysis from the Ovarian Cancer Association Consortium and The Cancer Genome Atlas.New approaches to pharmacotherapy of tumors of the nervous system during childhood and adolescence.Estrogen Enhances the Expression of the Multidrug Transporter Gene ABCG2-Increasing Drug Resistance of Breast Cancer Cells through Estrogen Receptors.miR-145 sensitizes breast cancer to doxorubicin by targeting multidrug resistance-associated protein-1.MYCN promotes neuroblastoma malignancy by establishing a regulatory circuit with transcription factor AP4.Effects of herbal products on the metabolism and transport of anticancer agents.The connections between neural crest development and neuroblastoma.Investigational ABC transporter inhibitors.Importance of ABCC1 for cancer therapy and prognosis.MRP1 and its role in anticancer drug resistance.Enzastaurin inhibits ABCB1-mediated drug efflux independently of effects on protein kinase C signalling and the cellular p53 status.Modulation of chemotherapeutic drug resistance in neuroblastoma SK-N-AS cells by the neural apoptosis inhibitory protein and miR-520f.ABCC4/MRP4: a MYCN-regulated transporter and potential therapeutic target in neuroblastoma.Combined use of anticancer drugs and an inhibitor of multiple drug resistance-associated protein-1 increases sensitivity and decreases survival of glioblastoma multiforme cells in vitro.Cathepsin D protects human neuroblastoma cells from doxorubicin-induced cell death.Clinicopathological impact of ABCC1/MRP1 and ABCC4/MRP4 in epithelial ovarian carcinoma.
P2860
Q33267205-32F887B6-1FA7-4098-9A94-4D6FCFD006D2Q33490314-86DDAB7F-B442-4812-AEEA-56DB80169945Q33586121-1DE7A037-E43A-4F04-88FA-14D30ED44733Q33763765-DF94E45D-BD47-4869-90D2-3B975CF73AABQ33911424-D4F11119-E246-4527-9BC5-B5871B9F36CAQ33947899-BFB2FFA4-1723-4B2F-B9CB-E48B1BF91164Q34204238-C1698922-248D-4170-9BAE-C09AF0932E55Q34351080-98C86DFD-590F-4A14-8661-98D95C830BD8Q34437369-B25C34E6-6A26-4996-8D31-12CBB484DA56Q34467407-FDB894DA-C1E3-439A-814C-87F1E921CB77Q34482630-696DD5F6-0314-4C6F-A421-889862D6BFB2Q34891827-564832B1-DC58-4D0C-8D45-5BE0987095B4Q35166695-E0FDD15E-CFEA-4630-B845-30813D8C53B1Q35597039-0B660E4B-77B4-4F36-98D7-52083D0845F1Q35745244-E97931A3-84BA-41DD-B70D-77D803174ABAQ35919726-049989A4-4618-4B35-A4B9-1F6C2CF3EC91Q36083299-E8BB7194-13AC-4A02-9694-AEA26330B5F3Q36378047-EE9096CD-A5E8-40AC-8CC8-DFEDBD930F1EQ36614690-B038F466-9AED-4BFA-944C-7001391E638EQ36876161-075E5AA2-E82F-47E6-B156-6A1F4BF4ED00Q37003304-E8CD4E4D-BB58-47D4-AE5E-23585455221BQ37071009-2D45DA3A-C44D-411A-818A-9BEC58B90B64Q37163339-BC209FA6-340D-446B-B2AF-F292695F3FC8Q37193077-D66FE010-4C2F-48B8-B3ED-8BD8110C9AA5Q37227494-19695696-E81F-455A-A4F3-BFB8A7F7B514Q37422646-43CAD5F0-C3CA-40BB-8EB8-F2B5C9669F0DQ37631633-D0BC3D0C-F95A-4B79-ABE4-E3C0616D6FEEQ37644927-557B5D28-3A90-4086-BCFA-B7F329868EACQ37688166-D2361FA0-3D6F-4638-B9AE-D89459147AB0Q37779320-4A398FD5-307B-44F1-A023-FAC33AA9111DQ37836006-511F62FA-C0DD-4FC4-8C58-E35C1FA67F1BQ38001734-D36DBFEF-1CE8-4C5C-889D-8C1B73454D96Q38199535-B9FA1D89-E59E-4FD6-8CDA-48B344F5378BQ38626237-87BEA6FD-0950-4B6C-9CFA-050AEB4C1397Q38902467-31DEE6C1-CCC4-4CA2-9AC6-180904DC2232Q38964665-E6F22B0C-E9DE-4502-9AEC-CAF9F5CCA73DQ39498028-C59DEC21-6084-46D2-B9F2-C78A6A6FE689Q39547831-86971814-48CB-4AB3-926C-519CDF8FD11CQ39970539-2DF33CE4-E557-4050-83B4-F8B127A6A4E5Q41811277-CBE62100-0C2B-431A-BE22-54199B02DFA8
P2860
Association of high-level MRP1 expression with poor clinical outcome in a large prospective study of primary neuroblastoma.
description
2006 nî lūn-bûn
@nan
2006 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Association of high-level MRP1 ...... tudy of primary neuroblastoma.
@ast
Association of high-level MRP1 ...... tudy of primary neuroblastoma.
@en
Association of high-level MRP1 ...... tudy of primary neuroblastoma.
@nl
type
label
Association of high-level MRP1 ...... tudy of primary neuroblastoma.
@ast
Association of high-level MRP1 ...... tudy of primary neuroblastoma.
@en
Association of high-level MRP1 ...... tudy of primary neuroblastoma.
@nl
prefLabel
Association of high-level MRP1 ...... tudy of primary neuroblastoma.
@ast
Association of high-level MRP1 ...... tudy of primary neuroblastoma.
@en
Association of high-level MRP1 ...... tudy of primary neuroblastoma.
@nl
P2093
P356
P1476
Association of high-level MRP1 ...... tudy of primary neuroblastoma.
@en
P2093
Claudia Flemming
Glenn M Marshall
Janice Smith
Michelle Haber
Murray D Norris
Sharon B Bordow
Wendy B London
P304
P356
10.1200/JCO.2005.01.6196
P407
P577
2006-04-01T00:00:00Z